286 related articles for article (PubMed ID: 26928287)
1. Anticancer drug released from near IR-activated prodrug overcomes spatiotemporal limits of singlet oxygen.
Rajaputra P; Bio M; Nkepang G; Thapa P; Woo S; You Y
Bioorg Med Chem; 2016 Apr; 24(7):1540-9. PubMed ID: 26928287
[TBL] [Abstract][Full Text] [Related]
2. Folate receptor-mediated enhanced and specific delivery of far-red light-activatable prodrugs of combretastatin A-4 to FR-positive tumor.
Nkepang G; Bio M; Rajaputra P; Awuah SG; You Y
Bioconjug Chem; 2014 Dec; 25(12):2175-88. PubMed ID: 25351441
[TBL] [Abstract][Full Text] [Related]
3. Far-red light activatable, multifunctional prodrug for fluorescence optical imaging and combinational treatment.
Bio M; Rajaputra P; Nkepang G; You Y
J Med Chem; 2014 Apr; 57(8):3401-9. PubMed ID: 24694092
[TBL] [Abstract][Full Text] [Related]
4. Far-Red Light-Activatable Prodrug of Paclitaxel for the Combined Effects of Photodynamic Therapy and Site-Specific Paclitaxel Chemotherapy.
Thapa P; Li M; Bio M; Rajaputra P; Nkepang G; Sun Y; Woo S; You Y
J Med Chem; 2016 Apr; 59(7):3204-14. PubMed ID: 26974508
[TBL] [Abstract][Full Text] [Related]
5. Quantitative modeling of the dynamics and intracellular trafficking of far-red light-activatable prodrugs: implications in stimuli-responsive drug delivery system.
Li M; Thapa P; Rajaputra P; Bio M; Peer CJ; Figg WD; You Y; Woo S
J Pharmacokinet Pharmacodyn; 2017 Dec; 44(6):521-536. PubMed ID: 28913666
[TBL] [Abstract][Full Text] [Related]
6. Near-infrared light-mediated photoactivation of a platinum antitumor prodrug and simultaneous cellular apoptosis imaging by upconversion-luminescent nanoparticles.
Min Y; Li J; Liu F; Yeow EK; Xing B
Angew Chem Int Ed Engl; 2014 Jan; 53(4):1012-6. PubMed ID: 24311528
[TBL] [Abstract][Full Text] [Related]
7. ROS-sensitive biomimetic nanocarriers modulate tumor hypoxia for synergistic photodynamic chemotherapy.
Liu H; Jiang W; Wang Q; Hang L; Wang Y; Wang Y
Biomater Sci; 2019 Aug; 7(9):3706-3716. PubMed ID: 31187794
[TBL] [Abstract][Full Text] [Related]
8. Site-specific and far-red-light-activatable prodrug of combretastatin A-4 using photo-unclick chemistry.
Bio M; Rajaputra P; Nkepang G; Awuah SG; Hossion AM; You Y
J Med Chem; 2013 May; 56(10):3936-42. PubMed ID: 23631389
[TBL] [Abstract][Full Text] [Related]
9. Theranostic Liposomes with Hypoxia-Activated Prodrug to Effectively Destruct Hypoxic Tumors Post-Photodynamic Therapy.
Feng L; Cheng L; Dong Z; Tao D; Barnhart TE; Cai W; Chen M; Liu Z
ACS Nano; 2017 Jan; 11(1):927-937. PubMed ID: 28027442
[TBL] [Abstract][Full Text] [Related]
10. A Dual Killing Strategy: Photocatalytic Generation of Singlet Oxygen with Concomitant Pt
Norman DJ; Gambardella A; Mount AR; Murray AF; Bradley M
Angew Chem Int Ed Engl; 2019 Oct; 58(40):14189-14192. PubMed ID: 31397963
[TBL] [Abstract][Full Text] [Related]
11. Anticancer activities of emetine prodrugs that are proteolytically activated by the prostate specific antigen (PSA) and evaluation of in vivo toxicity of emetine derivatives.
Akinboye ES; Rosen MD; Bakare O; Denmeade SR
Bioorg Med Chem; 2017 Dec; 25(24):6707-6717. PubMed ID: 29153549
[TBL] [Abstract][Full Text] [Related]
12. Near-Infrared-Activated Upconversion Nanoprobes for Sensitive Endogenous Zn
Hu P; Wang R; Zhou L; Chen L; Wu Q; Han MY; El-Toni AM; Zhao D; Zhang F
Anal Chem; 2017 Mar; 89(6):3492-3500. PubMed ID: 28220697
[TBL] [Abstract][Full Text] [Related]
13. PBPK modeling-based optimization of site-specific chemo-photodynamic therapy with far-red light-activatable paclitaxel prodrug.
Li M; Nguyen L; Subramaniyan B; Bio M; Peer CJ; Kindrick J; Figg WD; Woo S; You Y
J Control Release; 2019 Aug; 308():86-97. PubMed ID: 31299262
[TBL] [Abstract][Full Text] [Related]
14. Achieving traceless ablation of solid tumors without recurrence by mild photothermal-chemotherapy of triple stimuli-responsive polymer-drug conjugate nanoparticles.
Du C; Ding Y; Qian J; Zhang R; Dong CM
J Mater Chem B; 2019 Jan; 7(3):415-432. PubMed ID: 32254729
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of a photoresponsive doxorubicin/combretastatin A4 hybrid prodrug.
Liu W; Liang L; Zhao L; Tan H; Wu J; Qin Q; Gou X; Sun X
Bioorg Med Chem Lett; 2019 Feb; 29(3):487-490. PubMed ID: 30553736
[TBL] [Abstract][Full Text] [Related]
16. Self-assembling nanowires of an amphiphilic camptothecin prodrug derived from homologous derivative conjugation.
He D; Zhang W; Deng H; Huo S; Wang YF; Gong N; Deng L; Liang XJ; Dong A
Chem Commun (Camb); 2016 Dec; 52(98):14145-14148. PubMed ID: 27869268
[TBL] [Abstract][Full Text] [Related]
17. Photoswitchable anticancer activity via trans-cis isomerization of a combretastatin A-4 analog.
Sheldon JE; Dcona MM; Lyons CE; Hackett JC; Hartman MC
Org Biomol Chem; 2016 Jan; 14(1):40-9. PubMed ID: 26503632
[TBL] [Abstract][Full Text] [Related]
18. A cancer specific oxaliplatin-releasing Pt(iv)-prodrug.
Reshetnikov V; Arkhypov A; Julakanti PR; Mokhir A
Dalton Trans; 2018 May; 47(19):6679-6682. PubMed ID: 29708261
[TBL] [Abstract][Full Text] [Related]
19. Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy.
Wang Y; Xie Y; Li J; Peng ZH; Sheinin Y; Zhou J; Oupický D
ACS Nano; 2017 Feb; 11(2):2227-2238. PubMed ID: 28165223
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of paclitaxel and vorinostat co-prodrugs for overcoming drug resistance in cancer therapy in vitro.
Liu S; Zhang K; Zhu Q; Shen Q; Zhang Q; Yu J; Chen Y; Lu W
Bioorg Med Chem; 2019 Apr; 27(7):1405-1413. PubMed ID: 30819618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
